"10.1371_journal.pone.0127960","plos one","2015-06-03T00:00:00Z","Keith Tolley; Michael Hutchinson; Xiaojun You; Ping Wang; Bjoern Sperling; Ankush Taneja; Mohammed Kashif Siddiqui; Elizabeth Kinter","Tolley Health Economics Ltd., Buxton, United Kingdom; St. Vincents University Hospital, Dublin, Ireland; Biogen Idec Inc., Cambridge, MA, United States of America; HERON Commercializationâ€”A Parexel Company, Chandigarh, India","Conceived and designed the experiments: KT MKS. Performed the experiments: MKS AT. Analyzed the data: MKS AT KT MH XY PW BS EK. Contributed reagents/materials/analysis tools: MKS AT KT MH XY PW BS EK. Wrote the paper: MKS AT KT MH XY PW BS EK. Performed the data collection, analysis, and interpretation of data: MKS AT. Contributed to manuscript review and revisions: MKS AT KT MH XY PW BS EK. Participated in the interpretation of data: KT MH XY PW BS EK. Read and approved the final manuscript: KT MH XY PW BS AT MKS EK.","The authors have read the journals policy and the authors of this manuscript have the following competing interests: MKS and AT are employees of HERON, a company that received funding from Biogen Idec to conduct this study. KT receives consulting fees from Biogen Idec Inc. MH receives speaker bureau fees from Bayer Schering, Biogen Idec Inc., Merck Serono, and Novartis. XY, PW, BS, and EK are employees of Biogen Idec Inc. These interests did not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","06","Keith Tolley","KT",8,TRUE,2,2,8,8,TRUE,TRUE,FALSE,0,NA,FALSE
